Gastroenterology news and gastroenterology widget

Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, announced that Debiovision Inc., its Canadian affiliate, filed its Complete Response to the approvable letter received from the United States (U.S.) Food and Drug Administration (FDA) for Sanvar(R), or Debio 8609 (vapreotide acetate).

The National Comprehensive cancer Network (NCCN) announces important updates to the NCCN Guidelines on Colon and Rectal Cancers. These changes reflect leading developments in the treatment of patients with colon and rectal cancers and represent the standard of care in oncology in both community and academic settings.

SAN FRANCISCO (MedPage Today) -- patients with hepatitis C infection were significantly less likely to develop treatment-related depression when given prophylactic escitalopram (Lexapro), German investigators reported here.

SAN FRANCISCO (MedPage Today) -- Moderate coffee consumption may help slow the progression of liver disease related to hepatitis C, according to an observational study.

SAN FRANCISCO (MedPage Today) -- In patients with primary sclerosing cholangitis, treatment with high-dose ursodeoxycholic acid (UDCA) may cause more harm than good, according to a study reported here.

SAN FRANCISCO (MedPage Today) -- Pegylated interferon alpha2a is more effective in hepatitis C patients with specific genotypes than the alpha2b form of the drug, an Italian researcher said.